2023 Q4 Form 10-Q Financial Statement
#000149315223040554 Filed on November 13, 2023
Income Statement
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $340.6K | $119.0K | |
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $340.6K | $119.0K | $160.00 |
YoY Change | 189127.78% | 74275.0% | |
Operating Profit | -$119.0K | -$163.00 | |
YoY Change | 72906.13% | ||
Interest Expense | $853.5K | $804.4K | |
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $512.9K | $685.4K | -$160.00 |
YoY Change | -285055.56% | -428487.5% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | $512.9K | $685.4K | -$160.00 |
YoY Change | -285055.56% | -428487.5% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $0.06 | $0.08 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 8.140M shares | 8.140M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $46.78K | $62.65K | $54.02K |
YoY Change | -1.47% | 15.98% | |
Cash & Equivalents | $0.00 | $0.00 | $54.02K |
Short-Term Investments | |||
Other Short-Term Assets | $59.53K | $87.82K | |
YoY Change | 752.87% | ||
Inventory | |||
Prepaid Expenses | $59.53K | $87.82K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $106.3K | $184.8K | $54.02K |
YoY Change | 95.21% | 242.07% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $63.46M | $62.61M | |
YoY Change | |||
Other Assets | $0.00 | $13.71K | $411.5K |
YoY Change | -100.0% | -96.67% | |
Total Long-Term Assets | $63.46M | $62.62M | $411.5K |
YoY Change | 14216.12% | 15116.55% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $106.3K | $184.8K | $54.02K |
Total Long-Term Assets | $63.46M | $62.62M | $411.5K |
Total Assets | $63.57M | $62.81M | $465.6K |
YoY Change | 12671.08% | 13390.59% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $399.0K | $150.6K | $6.250K |
YoY Change | 933.2% | 2309.5% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $444.0K |
YoY Change | -100.0% | -100.0% | |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $409.0K | $160.6K | $450.3K |
YoY Change | -15.25% | -64.33% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $409.0K | $160.6K | $450.3K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $409.0K | $160.6K | $450.3K |
YoY Change | -15.25% | -64.33% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$302.9K | $37.69K | |
YoY Change | 2960.78% | ||
Common Stock | $214.00 | $214.00 | |
YoY Change | 23.7% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$302.7K | $37.90K | $15.28K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $63.57M | $62.81M | $465.6K |
YoY Change | 12671.08% | 13390.59% |
Cashflow Statement
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $512.9K | $685.4K | -$160.00 |
YoY Change | -285055.56% | -428487.5% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$50.20K | -$52.57K | -$320.00 |
YoY Change | 1180.61% | 16328.13% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | |
YoY Change | |||
Cash From Investing Activities | $0.00 | $0.00 | |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 34.32K | -2.250K | -81.11K |
YoY Change | -1409.92% | -97.23% | |
NET CHANGE | |||
Cash From Operating Activities | -50.20K | -52.57K | -320.0 |
Cash From Investing Activities | 0.000 | 0.000 | |
Cash From Financing Activities | 34.32K | -2.250K | -81.11K |
Net Change In Cash | -15.88K | -54.82K | -81.43K |
YoY Change | 142.81% | -32.68% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$50.20K | -$52.57K | -$320.00 |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q3 | us-gaap |
Deferred Costs
DeferredCosts
|
usd | |
CY2022Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q3 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
usd | |
us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
usd | ||
CY2022Q3 | TMTCU |
Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
|
usd | |
TMTCU |
Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
|
usd | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001879851 | ||
CY2022Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
usd | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
|
usd | |
TMTCU |
Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
|
usd | ||
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
usd | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | ||
TMTCU |
Cash Deposited Into Trust Account
CashDepositedIntoTrustAccount
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
usd | ||
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
usd | ||
TMTCU |
Payment Of Underwriting Discount
PaymentOfUnderwritingDiscount
|
usd | ||
TMTCU |
Reclassification Of Amount Due To Related Party To Promissory Note
ReclassificationOfAmountDueToRelatedPartyToPromissoryNote
|
usd | ||
TMTCU |
Deferred Offering Costs Charged To Apic
DeferredOfferingCostsChargedToAPIC
|
usd | ||
TMTCU |
Note Payable To Related Party Converted To Subscription Of Private Placement
NotePayableToRelatedPartyConvertedToSubscriptionOfPrivatePlacement
|
usd | ||
TMTCU |
Receivable From Related Party For Purchase Of Private Placement
ReceivableFromRelatedPartyForPurchaseOfPrivatePlacement
|
usd | ||
TMTCU |
Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
|
usd | ||
TMTCU |
Reclassification Of Ordinary Shares Subject To Redemption
ReclassificationOfOrdinarySharesSubjectToRedemption
|
usd | ||
TMTCU |
Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption
RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
|
usd | ||
TMTCU |
Issuance Of Representative Shares At Fair Value
IssuanceOfRepresentativeSharesAtFairValue
|
usd | ||
TMTCU |
Forfeiture Of Ordinary Shares
ForfeitureOfOrdinaryShares
|
usd | ||
CY2022Q3 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
usd | |
us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
usd | ||
CY2023Q3 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
usd | |
CY2022Q3 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
usd | |
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
usd | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41667 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
TMT Acquisition Corp | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
420 Lexington Ave | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 2446 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10170 | ||
dei |
City Area Code
CityAreaCode
|
(347) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
627-0058 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
8140000 | shares |
CY2023Q3 | us-gaap |
Cash
Cash
|
62651 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
47478 | usd |
CY2023Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
87817 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
6979 | usd |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
184786 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
54457 | usd |
CY2023Q3 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
13707 | usd |
CY2022Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
443284 | usd |
CY2023Q3 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
62606946 | usd |
CY2023Q3 | us-gaap |
Assets
Assets
|
62805439 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
497741 | usd |
CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
150594 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
38620 | usd |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
160594 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
482638 | usd |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
160594 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
482638 | usd |
CY2023Q3 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
6000000 | shares |
CY2022Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
6000000 | shares |
CY2023Q3 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.43 | |
CY2022Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.43 | |
CY2023Q3 | us-gaap |
Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
|
62606946 | usd |
CY2023Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2140000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2140000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1725000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1725000 | shares |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
214 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
173 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
24827 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
37685 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-9897 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
37899 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15103 | usd |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
62805439 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
497741 | usd |
CY2023Q3 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
30000 | usd |
us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
70000 | usd | |
CY2023Q3 | us-gaap |
Direct Operating Costs
DirectOperatingCosts
|
89000 | usd |
CY2022Q3 | us-gaap |
Direct Operating Costs
DirectOperatingCosts
|
163 | usd |
us-gaap |
Direct Operating Costs
DirectOperatingCosts
|
280003 | usd | |
us-gaap |
Direct Operating Costs
DirectOperatingCosts
|
346 | usd | |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-119000 | usd |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-163 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-350003 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-346 | usd | |
CY2023Q3 | TMTCU |
Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
|
804420 | usd |
TMTCU |
Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
|
1406946 | usd | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
685420 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-163 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
1056943 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-346 | usd | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15629 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15602 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-156 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15446 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-163 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15283 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15103 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
60000000 | usd |
CY2023Q1 | TMTCU |
Stock Issued During Period Value Proceeds From Sale Of Private Placement Units
StockIssuedDuringPeriodValueProceedsFromSaleOfPrivatePlacementUnits
|
3700000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
-1200000 | usd |
CY2023Q1 | TMTCU |
Stock Issued During Period Value Representative Shares Issued
StockIssuedDuringPeriodValueRepresentativeSharesIssued
|
1741500 | usd |
CY2023Q1 | TMTCU |
Adjustments To Additional Paid In Capital Other Offering Costs
AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts
|
-2668701 | usd |
CY2023Q1 | us-gaap |
Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
|
-58645200 | usd |
CY2023Q1 | TMTCU |
Adjustments To Additional Paid In Capital Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
|
3781346 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
-6336146 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-97180 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
290722 | usd |
CY2023Q2 | TMTCU |
Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
|
-602526 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
468703 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
156899 | usd |
CY2023Q3 | TMTCU |
Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
|
-804420 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
685420 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
685420 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
37899 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
1056943 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-346 | usd | |
TMTCU |
Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
|
1406946 | usd | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
10000 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
94545 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
111974 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-9371 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-322574 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9717 | usd | |
TMTCU |
Cash Deposited Into Trust Account
CashDepositedIntoTrustAccount
|
61200000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-61200000 | usd | |
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
60000000 | usd | |
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
3221664 | usd | |
TMTCU |
Payment Of Underwriting Discount
PaymentOfUnderwritingDiscount
|
1200000 | usd | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
483917 | usd | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
136259 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
61537747 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-136259 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
15173 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-145976 | usd | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
47478 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
200000 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
62651 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
54024 | usd |
TMTCU |
Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
|
1750 | usd | |
TMTCU |
Reclassification Of Amount Due To Related Party To Promissory Note
ReclassificationOfAmountDueToRelatedPartyToPromissoryNote
|
244018 | usd | |
TMTCU |
Deferred Offering Costs Charged To Apic
DeferredOfferingCostsChargedToAPIC
|
2668701 | usd | |
TMTCU |
Note Payable To Related Party Converted To Subscription Of Private Placement
NotePayableToRelatedPartyConvertedToSubscriptionOfPrivatePlacement
|
444018 | usd | |
TMTCU |
Receivable From Related Party For Purchase Of Private Placement
ReceivableFromRelatedPartyForPurchaseOfPrivatePlacement
|
34318 | usd | |
TMTCU |
Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
|
3781346 | usd | |
TMTCU |
Reclassification Of Ordinary Shares Subject To Redemption
ReclassificationOfOrdinarySharesSubjectToRedemption
|
58645200 | usd | |
TMTCU |
Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption
RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
|
7743092 | usd | |
TMTCU |
Issuance Of Representative Shares At Fair Value
IssuanceOfRepresentativeSharesAtFairValue
|
1741500 | usd | |
TMTCU |
Forfeiture Of Ordinary Shares
ForfeitureOfOrdinaryShares
|
23 | usd | |
dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2021-07-06 | ||
CY2023Q3 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.20 | |
CY2023Q3 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.20 | |
CY2023Q3 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.20 | |
CY2023Q3 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.20 | |
TMTCU |
Cash Deposited Into Trust Account
CashDepositedIntoTrustAccount
|
61200000 | usd | |
CY2023Q3 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
3868701 | usd |
us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
1200000 | usd | |
CY2023Q3 | us-gaap |
Other Deferred Costs Net
OtherDeferredCostsNet
|
2668701 | usd |
CY2023Q3 | us-gaap |
Cash
Cash
|
62651 | usd |
CY2023Q3 | TMTCU |
Working Capital
WorkingCapital
|
24192 | usd |
CY2023Q3 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
600000 | usd |
CY2023Q3 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
0.10 | |
us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
1800000 | usd | |
CY2023Q3 | us-gaap |
Share Price
SharePrice
|
0.30 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_849_eus-gaap--UseOfEstimates_z7alVx4U5nZf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zTMyc108n7o2">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | usd |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zgvpudaEAYI6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zrJZUw4Rutvh">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zAAdUJ3L07y7" title="Cash FDIC insured amount">250,000</span>. As on September 30, 2023, and December 31, 2022, the Company did not experience losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2023Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
685420 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-163 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
1056943 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-346 | usd | |
CY2023Q3 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-804420 | usd |
us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-1406946 | usd | |
us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
6336146 | usd | |
CY2023Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-119000 | usd |
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-163 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-6686149 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-346 | usd | |
CY2023Q3 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.43 | |
CY2022Q1 | TMTCU |
Business Acquisitions Name Of Acquired Entity
BusinessAcquisitionsNameOfAcquiredEntity
|
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of their founder shares until the earlier of: (A) one year after the completion of the initial Business Combination or (B) subsequent to our Business Combination, the last sale price of the ordinary share (x) equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property | |
CY2023Q3 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
30000 | usd |
us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
70000 | usd | |
CY2023Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Holders of Class A and Class B ordinary shares were entitled to one vote for each share. | ||
CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2140000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2140000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1725000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1725000 | shares |
us-gaap |
Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
|
Simultaneously with the closing of the IPO, the Company issued to Maxim Partners LLC, pursuant to the underwriting agreement, 270,000 Representative Shares (the “Representative Shares”). The underwriter has agreed not to transfer, assign or sell any such Representative Shares without prior consent of the Company until the completion of the initial Business Combination. | ||
TMTCU |
Fair Value Of Representative Shares
FairValueOfRepresentativeShares
|
1741500 | usd | |
CY2022Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
0 | usd |
CY2023Q1 | us-gaap |
Share Price
SharePrice
|
6.45 |